Insights into Early Interactions on Innovative Developments with European Regulators
This analysis frames the content and the type of topics discussed during ITF briefing meetings. Moreover, it describes the type of regulatory feedback provided to medicine developers and identified potential for improvement of these early interactions. Therefore, this analysis emphasises the role of ITF briefing meetings in fostering innovation in medicine.
Authors
- Falk Ehmann (ORCID: https://orcid.org/0000-0001-9226-027X)
- Valentina Cordo’ (ORCID: https://orcid.org/0000-0003-1373-513X)
- David W. Uster
- Emmanuel Cormier
Institutions
- European Medicines Agency (NL)
Publication Details
- Journal
- Therapeutic Innovation & Regulatory Science
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1007/s43441-024-00686-7
- Citations
- 3
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.70